Scarica l'app Stockscreener
22.51
0.46%
-0.13
Nurix Therapeutics Inc Azioni (NRIX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-02-29 | 2023-11-30 | 2023-08-31 | 2023-05-31 | 2023-02-28 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
9.41%
16.59
|
15.16 | 18.47 | 30.68 | 12.69 |
Operating Expenses
|
2.17%
61.80
|
60.49 | 58.48 | 57.44 | 55.64 |
| Benefits Costs and Expenses |
73.74%
58.01
|
220.94 | - | - | - |
| Costs And Expenses |
17.49%
58.01
|
49.38 | 58.48 | 57.44 | 55.64 |
| Depreciation and Amortization |
5.74%
2.045
|
1.934 | 1.951 | 1.896 | 1.752 |
| Operating Income/Loss |
0.25%
-45.22
|
-45.33 | -40.01 | -26.77 | -42.95 |
| Income/Loss From Continuing Operations Before Tax |
79.87%
-41.43
|
-205.78 | 18.47 | -24.28 | -40.73 |
| Income Tax Expense/Benefit |
0.09
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
1.04%
-41.52
|
-41.96 | -36.98 | -24.28 | -40.73 |
|
Net Income/Loss
|
1.04%
-41.52
|
-41.96 | -36.98 | -24.28 | -40.73 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
49,627%
54.90
|
0.1104 | 54.39 | 54.26 | 54.03 |
| Diluted Average Shares |
49,627%
54.90
|
0.1104 | 54.39 | 54.26 | 54.03 |
| Basic Earnings Per Share |
1.30%
-0.76
|
-0.77 | -0.68 | -0.45 | -0.75 |
| Diluted Earnings Per Share |
1.30%
-0.76
|
-0.77 | -0.68 | -0.45 | -0.75 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.42%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):